106. Wells, J. C., et al. (2021, March 1). An analysis of contemporary oncology randomized clinical trials from low/middle income vs. high-income countries. JAMA Oncology, 7(3), 379–385. https://pubmed.ncbi.nlm.nih.gov/33507236/ 107. Hamel, L. M., et al. (2016, December 1). Barriers to clinical trial enrolment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327–337. https://pmc.ncbi.nlm.nih.gov/articles/PMC5131730/ 108. Kwiatkowski, K., Coe, K., Bailar, J. C., & Swanson, G. M. (2013). Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? Cancer, 119(13), 2956–2963. https://pubmed.ncbi.nlm.nih.gov/23674318/ 109. Institute for Health Metrics and Evaluation. (2021, May 16). Global Burden of Disease 2021: Findings from the GBD 2021 Study. https://www.healthdata.org/research-analysis/library/global-burden-disease-2021-findings-gbd-2021-study 110. World Economic Forum & McKinsey Health Institute. (2024). Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion- dollar-opportunity-to-improve-lives-and-economies 111. UNICEF. (2024). 5 fast facts about HPV and cervical cancer. https://www.unicef.org/stories/fast-facts-hpv-cervical- cancer#:~:text=Cervical%20cancer%20has%20an%20overwhelmingly,ever%20screened%20for%20cervical%20cancer . 112. Zarocostas, J. (2024). Renewed calls to scale-up cervical cancer screening. The Lancet World Report, 403(10429). https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00408-2/abstract 113. Djibril, M., et al. (2022, June 1). Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiology, 72, 101930. https://pmc.ncbi.nlm.nih.gov/articles/ PMC8864323/ 114. Bruni, L., et al. (2022). Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: A review and synthetic analysis. The Lancet Global Health, 10(8), e1115–e1127. https://www. thelancet.com/journals/langlo/article/PIIS2214-109X(22)00241-8/fulltext 115. Bairey Merz, C. N., et al. (2017, July). Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: The Women’s Heart Alliance. Journal of the American College of Cardiology, 70(2), 123–132. https://www.jacc.org/ doi/10.1016/j.jacc.2017.05.024 116. Khamis, R.Y., Ammari, T., & Mikhail, G. W. (2016). Gender differences in coronary heart disease. Heart, 102, 1142–1149. https://heart.bmj.com/content/102/14/1142 117. Rizzoli, P . (2022, February 15). Health disparities and headache treatment. Harvard Health Publishing. https://www.health. harvard.edu/blog/health-disparities-and-headache-treatment-202202152685 118. U.S. Department of Health and Human Services. (1999, December 31). Access and utilization of new antidepressant and antipsychotic medications. https://aspe.hhs.gov/reports/access-utilization-new-antidepressant-antipsychotic-medications 119. Charles, A. C., et al. (2024, April). Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache, 64(4), 333–341. https://pubmed.ncbi.nlm.nih.gov/38466028/ 120. Verhaak, A. M. S., et al. (2020, January 20). Migraine diagnosis and treatment: A knowledge and needs assessment of women’s healthcare providers. Headache, 61(1), 69–79. https://pmc.ncbi.nlm.nih.gov/articles/ PMC8771914/#:~:text=A%20wider%20variety%20of%20contraceptives,for%20ischaemic%20stroke%20in%20women 121. Indian Council of Medical Research. (n.d.). Breast cancer guidelines. Retrieved November 14. 2024, from https://main. icmr.nic.in/sites/default/files/guidelines/Breast_Cancer.pdf 122. American Association for Cancer Research. (2021). Estimating the breast cancer burden in Germany and the U.S. Cancer Prevention Research, 14(6), 627–635. https://aacrjournals.org/cancerpreventionresearch/article/14/6/627/666489/ Estimating-the-Breast-Cancer-Burden-in-Germany-and 123. Mann, R. M., et al. (2022). Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). European radiology, 32(6), 4036–4045. https://doi.org/10.1007/s00330- 022-08617-6 124. McKinsey & Company. (2024). Health-related climate adaptation: How to innovate and scale global action for local needs. https://www.mckinsey.com/mhi/our-insights/health-related-climate-adaptation-how-to-innovate-and-scale-global-action- for-local-needs 125. Kunda, N. K., et al. (2019). Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9. Human vaccines & immunotherapeutics, 15(7–8), 1995–2002. https://doi.org/10.1080/21645515.2019.15 93727 126. Mittra, I., et al. (2021, February). Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: Prospective, cluster randomized controlled trial in Mumbai. The Lancet Oncology, 24(372), 930–940. https://pubmed.ncbi.nlm.nih.gov/33627312/ 127. Gawande, A. (2007, December 2). The checklist. The New Yorker. https://www.newyorker.com/magazine/2007/12/10/ the-checklist 128. Allen, J. T. (2024, February 1). Effective menopause education methods: Addressing the needs of current medical trainees. Menopause, 31(2), 89–90. https://pubmed.ncbi.nlm.nih.gov/38270900/ 129. Kling, J. M., et al. (2019, February). Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: A cross-sectional survey. Mayo Clinic Proceedings, 94(2), 242–253. https://pubmed.ncbi.nlm.nih.gov/30711122/ Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 57

Blueprint to Close the Women%E2%80%99s Health Gap 2025